Michael J. LaBarre
CIK 1507174 · SVP, CHIEF TECHNICAL OFFICER · last filed 2025-02-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
65
Lifetime Open-Market Net
-$25.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, CHIEF TECHNICAL OFFICER | 173,856 | — | — | -$25.16M | 65 | 2025-02-27 |
Recent Filings · Page 5 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-01 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | — | -$790.2K | EDGAR |
| 2021-07-15 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +14,685 | $96.2K | EDGAR |
| 2021-07-06 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | — | -$1.58M | EDGAR |
| 2021-05-03 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Exer (M) | +11,311 | $127.7K | EDGAR |
| 2021-04-01 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | — | -$897.1K | EDGAR |
| 2021-03-01 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Sell (S) | −18,324 | -$839.4K | EDGAR |
| 2021-02-22 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +4,439 | -$212.5K | EDGAR |
| 2021-02-17 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-16 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +3,499 | -$113.2K | EDGAR |
| 2021-02-12 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +10,386 | -$282.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.